However, they said, the main challenges lie in securing sufficiently high vaccine coverage and respond quickly enough to immune-escape variants of SARS-CoV-2, the virus that causes COVID-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iB8fCo
via IFTTT
0 comments:
Post a Comment